Of all the many platforming heroes we’d love to bring to VR, we have to admit Sonic the Hedgehog wasn’t one we’d previously considered. As we all know, Sega’s Blue Bullet has gotta go fast, a little too fast for VR comfort levels. That hasn’t stopped a fan from making an unofficial version of the […]
NYS Entity Status
NYS Filing Date
NOVEMBER 13, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC PROFESSIONAL CORPORATION
2013 - HEALTHWELL PHYSICAL THERAPY, P.C.
Around the Web
- VR modder re-creates Sonic the Hedgehog’s Green Hill Zone
By Jamie Feltham, Upload VR - Sunday Oct 15, 2017
- Listing of the Day: Toronto Forest Hill
Friday Jun 23, 2017
The sprawling steel-frame and concrete mansion sits in Toronto's most prestigious and affluent neighborhoods.
- Bots are becoming highly skilled assistants in physical therapy
By Michal Prywata, Bionik Laboratories - Sunday Oct 15, 2017
GUEST: Within the last decade, we’ve seen incredible progress in the fields of robotics and artificial intelligence. Innovators have been seeking out ways to meld man and machine and, in some areas, remove man altogether. In robotics, we’re seeing delivery drones, security robots, and more. In AI, chatbots, self-driving cars, and voice recognition have all made […]
- Neighborhood Joint: Staubitz Market in Brooklyn: 100 Years of Sawdust, Steaks and Chops
By ANDREW COTTO - Wednesday Jun 14, 2017
A display contains frozen items, and the shelves are stocked with jars and cans. But there’s just one reason to visit this Boerum Hill business: meat.
- Neighborhoods That Play Hard to Get
By STEFANOS CHEN - Friday Aug 11, 2017
In some New York neighborhoods, the housing stock is great, but turnover is so low, word of mouth is the best search engine.
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]